Explore every episode of the podcast The European Tumour Group Podcast

In this episode, we delve into the fascinating journey of aspirin and its transformative role in cancer prevention with the renowned Professor Sir John Burn. A pioneer in genetics and cancer research, Sir John recounts the incredible story of how a simple over-the-counter medication became a game-changer for individuals with Lynch syndrome—a condition that significantly increases the risk of several cancers, including bowel and endometrial cancer.

Discover the science behind aspirin's preventive powers, the groundbreaking clinical trials that reshaped our understanding of cancer prevention, and the challenges and triumphs along the way. From the earliest hypotheses to the latest breakthroughs, Sir John Burn shares his insights into this extraordinary chapter in modern medicine, blending scientific expertise with a personal passion for improving patient outcomes.

This episode is a must-listen for anyone curious about the intersection of genetics, cancer prevention, and one of the most widely used drugs in the world.